Teachers Advisors’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$10.2M Sell
7,529
-4,467
-37% -$6.06M 0.01% 992
2018
Q4
$13.9M Buy
11,996
+221
+2% +$248K 0.02% 767
2018
Q3
$17.9M Sell
11,775
-1,170
-9% -$1.8M 0.02% 778
2018
Q2
$20.3M Buy
12,945
+671
+5% +$875K 0.03% 727
2018
Q1
$14.2M Sell
12,274
-357
-3% -$470K 0.02% 887
2017
Q4
$15M Sell
12,631
-8,234
-39% -$10.3M 0.02% 874
2017
Q3
$28.1M Sell
20,865
-586
-3% -$618K 0.04% 520
2017
Q2
$17.3M Buy
21,451
+2,714
+14% +$1.89M 0.02% 735
2017
Q1
$11.5M Buy
18,737
+261
+1% +$159K 0.02% 922
2016
Q4
$9.88M Buy
18,476
+662
+4% +$331K 0.02% 964
2016
Q3
$9.22M Buy
17,814
+151
+0.9% +$71.1K 0.02% 976
2016
Q2
$7.25M Buy
17,663
+2,335
+15% +$1.07M 0.01% 1020
2016
Q1
$8.16M Buy
15,328
+332
+2% +$165K 0.01% 951
2015
Q4
$11.4M Buy
14,996
+343
+2% +$228K 0.02% 804
2015
Q3
$8.03M Buy
14,653
+11,868
+426% +$7.19M 0.02% 952
2015
Q2
$1.64M Buy
2,785
+2,259
+429% +$1.31M ﹤0.01% 1821
2015
Q1
$413K Buy
526
+172
+49% +$133K ﹤0.01% 2542
2014
Q4
$242K Buy
+354
New +$228K ﹤0.01% 2827

Other funds holding KYNB

Teachers Advisors's KYNB Position: Q1 2019 in Review

Teachers Advisors reduced its Kyntra Bio (KYNB) stake by 37% in Q1 2019, selling an estimated $6.06M and leaving 7,529 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #992.

Teachers Advisors first reported a position in KYNB in Q4 2014 and has held it in 18 quarters since. The position peaked at $28.1M in Q3 2017. 225 funds tracked by Wall St. Rank hold KYNB as of Q1 2019.

  • Teachers Advisors held 7,529 shares of Kyntra Bio worth $10.2M as of Q1 2019.
  • Teachers Advisors sold 4,467 Kyntra Bio shares in Q1 2019, an estimated $6.06M.
  • Kyntra Bio made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #992 holding.
  • Teachers Advisors first reported a position in Kyntra Bio in Q4 2014 and has held it in 18 quarters since.
  • Teachers Advisors's Kyntra Bio position peaked at $28.1M in Q3 2017.
  • 225 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.